|
Categories |
Biomarkers, Diagnostics |
|
Development Stage |
Working prototype |
|
Patent Status |
Provisional patent filed |
|
Market Size |
The 2007 global market for biomarkers was $5.6 billion, increasing to over $12.8 billion by 2012, at a compound average annual growth rate (CAGR) of 18%. |
Highlights
-
Saliva is an easily obtainable body fluid to use when searching for disease biomarkers, hormones etc.
-
Amylases constitute 60% of saliva fluids and mask the presence of other protein components
-
Device removes amylase from oral and other body fluids to increase efficiency of analysis for other proteins . The device also enables if desired to obtain the amylase separately for any desired purpose
-
Working prototype completed; characterization of results obtained from device needed
Our Innovation
-
Device that removes amylase from saliva and other body fluids, such as sweat, lacrimal, gastro-intestinal, and pancreatic fluids, serum and urine. The device also enables to obtain the amylase separately
Key Features
-
Low-cost, durable, easy-to-use device
-
Provides higher volume of sample for analysis
-
Removes broad spectrum of amylase
-
Removes fluid debris, eliminating need for pre-separation treatment of sample
Development Milestones
-
Characterization of results obtained from prototype
The Opportunity
-
Possible applications in biomarker discovery, clinical trials and molecular diagnostics
-
Biomarkers reduce time and cost for Phase I and II clinical trials by replacing clinical endpoints, producing over $200 million in revenue in 2007 and expected to quintuple in the next four years
-
Biomarkers promise a smoother integration of diagnostics and therapeutics
- Biomarkers required for personalized medicine
1586128900.png)